Regulatory Due Diligence Becomes More Critical in a “Hot” Year for Deals in the FDA Space
FDA Law Blog
JANUARY 8, 2024
Claud — As the calendar turned to 2024, we came across the usual end-of year looks back and projections ahead. In a “hot” deal market, its worthwhile reiterating the fundamentals of regulatory due diligence that don’t change, no matter how attractive the deal or how short the window is to seize the opportunity. By John W.M.
69 
Let's personalize your content